Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Vanguard Windsor Investor Shares

iShares US Medical Devices ETF

State St S&P 500® Indx SL Cl III

Champlain Mid Cap Fund, LLC

Ninety One GSF Glb Frchs I Acc USD

JPMorgan Large Cap Growth I

Blackrock Eq Idx Fund CF

BGF World Healthscience A2

Vanguard Mid-Cap Growth ETF

Invesco S&P 500® Equal Weight ETF

Vanguard Health Care Inv

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

iShares Core S&P 500 ETF

Vanguard Growth Index Investor

Vanguard Mid Cap Index Institutional

The Health Care Select Sector SPDR® ETF

Vanguard Institutional Index I

Vanguard Group Inc

BlackRock Inc

Ninety One UK Limited

AllianceBernstein L.P.

Deutsche Bank AG

UBS Asset Mgmt Americas Inc

Morgan Stanley - Brokerage Accounts

Legal & General Group PLC

Northern Trust Corp

Sands Capital Management, LLC

Wellcome Trust Ltd

Marshall Wace Asset Management Ltd

Wellington Management Company LLP

State Street Corp

Bank of New York Mellon Corp

Geode Capital Management, LLC

Fisher Asset Management, LLC

NORGES BANK

JPMorgan Chase & Co

Brown Advisory Holdings Inc

Edwards Lifesciences Corp

Mr. Bernard J. Zovighian

CEO & Director

Mr. Scott B. Ullem

Corporate VP & CFO

Mr. Donald E. Bobo Jr.

Corporate Vice President of Strategy & Corporate Development

Mr. Larry L. Wood

Corporate VP and Group President of TAVR & Surgical Structural Heart

Mr. Andrew M. Dahl

Principal Accounting Officer, Senior VP & Corporate Controller

Dr. Todd J. Brinton FACC, M.D.

Corporate VP of Advanced Technology & Chief Scientific Officer

Mr. Mark  Wilterding

Vice President of Investor Relations

Mr. Arnold A. Pinkston J.D.

Corporate VP & General Counsel

Mr. Dirksen J. Lehman

Corporate Vice President of Public Affairs

Ms. Christine Z. McCauley

Corporate Vice President of Human Resources

Edwards Lifesciences Corp (EW) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Edwards Lifesciences Corp (EW) Earnings Report Date and History | NYSE

EW's next earnings is on February 4, 2025 (Before Market Open)

When is the earnings report for EW?

EW Earnings History

EW Stock Discussion Forum and Message Board

News for NYSE: EW